Eli Lilly & Co. (NYSE:LLY)

CAPS Rating: 4 out of 5

The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases.

Recs

0
Player Avatar sshbeeb (< 20) Submitted: 10/12/2011 1:19:39 PM : Outperform Start Price: $35.39 LLY Score: +7.63

They are owners of several frequently used medicines for common chronic conditions.

Featured Broker Partners


Advertisement